Literature DB >> 2900086

Cancer promoting potential of different strains of Fusarium moniliforme in a short-term cancer initiation/promotion assay.

W C Gelderblom1, W F Marasas, K Jaskiewicz, S Combrinck, D J van Schalkwyk.   

Abstract

A short-term cancer initiation/promotion bioassay was established to screen 10 toxic strains of Fusarium moniliforme for their cancer promoting activity in rats. The assay consisted of a four week 'promoting' treatment, effected by incorporating culture material (5%) of each strain into the diet, commencing one week after an initiation treatment with diethylnitrosamine (DEN, 200 mg/kg). The appearance of gamma-glutamyltranspeptidase-positive (GGT+) foci was used as an indication of promoting activity. Three out of 10 strains of F. moniliforme obtained from corn from a high risk area for esophageal cancer in Transkei, southern Africa, had significant cancer promoting activity. A highly significant correlation was found between toxicity expressed as reduction in body weight gain and cancer promoting activity. This finding suggests that the compounds responsible for the hepatotoxicity and hepatocarcinogenicity of F. moniliforme could be identical.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900086     DOI: 10.1093/carcin/9.8.1405

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  21 in total

1.  Differential cytotoxicity and mycotoxin content among isolates of Fusarium moniliforme.

Authors:  W P Norred; C W Bacon; R D Plattner; R F Vesonder
Journal:  Mycopathologia       Date:  1991-07       Impact factor: 2.574

2.  Duckling toxicity and the production of fumonisin and moniliformin by isolates in the A and E mating populations of Gibberella fujikuroi (Fusarium moniliforme).

Authors:  J F Leslie; W F Marasas; G S Shephard; E W Sydenham; S Stockenström; P G Thiel
Journal:  Appl Environ Microbiol       Date:  1996-04       Impact factor: 4.792

3.  Comparative cytotoxicity of fumonisin B1 in two cell lines derived from normal human bronchial epithelial cells using four distinct bioassay techniques.

Authors:  C Lewis; J Smith; J Anderson; R Freshney
Journal:  Mycotoxin Res       Date:  1999-06       Impact factor: 3.833

4.  Production of fumonisin B1 and B 2 byFusarium moniliforme isolated from Korean corn kerneis for feed.

Authors:  L Ung-Soo; L Myong-Yur; S Kwang-Sop; M Yun-Sik; C Chae-Min; Y Ueno
Journal:  Mycotoxin Res       Date:  1994-09       Impact factor: 3.833

5.  A limited survey of fumonisins in corn and corn-based products in Asian countries.

Authors:  Y Ueno; S Aoyama; Y Sugiura; D S Wang; U S Lee; E Y Hirooka; S Hara; T Karki; G Chen; S Z Yu
Journal:  Mycotoxin Res       Date:  1993-03       Impact factor: 3.833

6.  Mutagenicity of potentially carcinogenic mycotoxins produced byFusarium moniliforme.

Authors:  W C Gelderblom; S D Snyman
Journal:  Mycotoxin Res       Date:  1991-09       Impact factor: 3.833

7.  Survey of fumonisin production by Fusarium species.

Authors:  P G Thiel; W F Marasas; E W Sydenham; G S Shephard; W C Gelderblom; J J Nieuwenhuis
Journal:  Appl Environ Microbiol       Date:  1991-04       Impact factor: 4.792

8.  Fumonisins and Alternaria alternata lycopersici toxins: sphinganine analog mycotoxins induce apoptosis in monkey kidney cells.

Authors:  W Wang; C Jones; J Ciacci-Zanella; T Holt; D G Gilchrist; M B Dickman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

9.  Production of fumonisins by Fusarium verticillioides strains on solid and in a defined liquid medium--effects of L-methionine and inoculum.

Authors:  Hester Francis Vismer; Petra Wilhelmina Snijman; Walter Friedrich Otto Marasas; Dirk Jacobus van Schalkwyk
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

10.  Comparative studies of hepatotoxicity and fumonisin B1 and B2 content of water and chloroform/methanol extracts of Fusarium moniliforme strain MRC 826 culture material.

Authors:  K A Voss; R D Plattner; C W Bacon; W P Norred
Journal:  Mycopathologia       Date:  1990-11       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.